nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—ABCC1—Mitoxantrone—multiple sclerosis	0.256	0.706	CbGbCtD
Zoledronate—ABCC1—Methotrexate—multiple sclerosis	0.107	0.294	CbGbCtD
Zoledronate—GGPS1—brainstem—multiple sclerosis	0.0114	0.0859	CbGeAlD
Zoledronate—GGPS1—retina—multiple sclerosis	0.011	0.0829	CbGeAlD
Zoledronate—GGPS1—medulla oblongata—multiple sclerosis	0.00793	0.0599	CbGeAlD
Zoledronate—GGPS1—midbrain—multiple sclerosis	0.00725	0.0548	CbGeAlD
Zoledronate—GGPS1—spinal cord—multiple sclerosis	0.00707	0.0534	CbGeAlD
Zoledronate—GGPS1—nervous system—multiple sclerosis	0.00596	0.045	CbGeAlD
Zoledronate—GGPS1—central nervous system—multiple sclerosis	0.00574	0.0433	CbGeAlD
Zoledronate—GGPS1—cerebellum—multiple sclerosis	0.00561	0.0424	CbGeAlD
Zoledronate—CA14—medulla oblongata—multiple sclerosis	0.00474	0.0358	CbGeAlD
Zoledronate—GGPS1—brain—multiple sclerosis	0.00456	0.0344	CbGeAlD
Zoledronate—CA14—midbrain—multiple sclerosis	0.00433	0.0327	CbGeAlD
Zoledronate—CA14—spinal cord—multiple sclerosis	0.00423	0.0319	CbGeAlD
Zoledronate—FDPS—medulla oblongata—multiple sclerosis	0.00366	0.0276	CbGeAlD
Zoledronate—CA14—cerebellum—multiple sclerosis	0.00335	0.0253	CbGeAlD
Zoledronate—FDPS—midbrain—multiple sclerosis	0.00334	0.0252	CbGeAlD
Zoledronate—FDPS—spinal cord—multiple sclerosis	0.00326	0.0246	CbGeAlD
Zoledronate—CA12—nervous system—multiple sclerosis	0.00278	0.021	CbGeAlD
Zoledronate—FDPS—nervous system—multiple sclerosis	0.00275	0.0208	CbGeAlD
Zoledronate—CA14—brain—multiple sclerosis	0.00272	0.0206	CbGeAlD
Zoledronate—CA2—brainstem—multiple sclerosis	0.00272	0.0206	CbGeAlD
Zoledronate—CA12—central nervous system—multiple sclerosis	0.00267	0.0202	CbGeAlD
Zoledronate—FDPS—central nervous system—multiple sclerosis	0.00265	0.02	CbGeAlD
Zoledronate—CA2—retina—multiple sclerosis	0.00263	0.0198	CbGeAlD
Zoledronate—FDPS—cerebellum—multiple sclerosis	0.00259	0.0195	CbGeAlD
Zoledronate—CA12—brain—multiple sclerosis	0.00212	0.016	CbGeAlD
Zoledronate—FDPS—brain—multiple sclerosis	0.0021	0.0159	CbGeAlD
Zoledronate—CA2—medulla oblongata—multiple sclerosis	0.0019	0.0143	CbGeAlD
Zoledronate—CA2—midbrain—multiple sclerosis	0.00173	0.0131	CbGeAlD
Zoledronate—CA2—spinal cord—multiple sclerosis	0.00169	0.0128	CbGeAlD
Zoledronate—ABCC1—cerebellum—multiple sclerosis	0.0015	0.0113	CbGeAlD
Zoledronate—CA2—nervous system—multiple sclerosis	0.00143	0.0108	CbGeAlD
Zoledronate—CA2—central nervous system—multiple sclerosis	0.00137	0.0104	CbGeAlD
Zoledronate—CA2—cerebellum—multiple sclerosis	0.00134	0.0101	CbGeAlD
Zoledronate—ABCC1—brain—multiple sclerosis	0.00122	0.00921	CbGeAlD
Zoledronate—CA2—brain—multiple sclerosis	0.00109	0.00823	CbGeAlD
Zoledronate—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00033	0.000654	CcSEcCtD
Zoledronate—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00033	0.000654	CcSEcCtD
Zoledronate—Paraesthesia—Prednisolone—multiple sclerosis	0.00033	0.000654	CcSEcCtD
Zoledronate—Tachycardia—Triamcinolone—multiple sclerosis	0.00033	0.000654	CcSEcCtD
Zoledronate—Mental disorder—Prednisone—multiple sclerosis	0.000329	0.000653	CcSEcCtD
Zoledronate—Nausea—Azathioprine—multiple sclerosis	0.000329	0.000652	CcSEcCtD
Zoledronate—Tachycardia—Methylprednisolone—multiple sclerosis	0.000329	0.000652	CcSEcCtD
Zoledronate—Skin disorder—Methylprednisolone—multiple sclerosis	0.000327	0.000649	CcSEcCtD
Zoledronate—Erythema—Prednisone—multiple sclerosis	0.000327	0.000648	CcSEcCtD
Zoledronate—Malnutrition—Prednisone—multiple sclerosis	0.000327	0.000648	CcSEcCtD
Zoledronate—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000327	0.000647	CcSEcCtD
Zoledronate—Agranulocytosis—Methotrexate—multiple sclerosis	0.000327	0.000647	CcSEcCtD
Zoledronate—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000326	0.000646	CcSEcCtD
Zoledronate—Convulsion—Dexamethasone—multiple sclerosis	0.000325	0.000645	CcSEcCtD
Zoledronate—Convulsion—Betamethasone—multiple sclerosis	0.000325	0.000645	CcSEcCtD
Zoledronate—Hypertension—Betamethasone—multiple sclerosis	0.000324	0.000643	CcSEcCtD
Zoledronate—Hypertension—Dexamethasone—multiple sclerosis	0.000324	0.000643	CcSEcCtD
Zoledronate—Asthenia—Mitoxantrone—multiple sclerosis	0.000321	0.000637	CcSEcCtD
Zoledronate—Myalgia—Betamethasone—multiple sclerosis	0.00032	0.000634	CcSEcCtD
Zoledronate—Myalgia—Dexamethasone—multiple sclerosis	0.00032	0.000634	CcSEcCtD
Zoledronate—Anxiety—Dexamethasone—multiple sclerosis	0.000319	0.000632	CcSEcCtD
Zoledronate—Anxiety—Betamethasone—multiple sclerosis	0.000319	0.000632	CcSEcCtD
Zoledronate—Discomfort—Betamethasone—multiple sclerosis	0.000316	0.000626	CcSEcCtD
Zoledronate—Discomfort—Dexamethasone—multiple sclerosis	0.000316	0.000626	CcSEcCtD
Zoledronate—Hypotension—Methylprednisolone—multiple sclerosis	0.000315	0.000624	CcSEcCtD
Zoledronate—Pain—Prednisolone—multiple sclerosis	0.000314	0.000623	CcSEcCtD
Zoledronate—Urinary tract disorder—Methotrexate—multiple sclerosis	0.00031	0.000615	CcSEcCtD
Zoledronate—Vision blurred—Prednisone—multiple sclerosis	0.000308	0.000611	CcSEcCtD
Zoledronate—Urethral disorder—Methotrexate—multiple sclerosis	0.000308	0.00061	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000308	0.00061	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000307	0.000609	CcSEcCtD
Zoledronate—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000307	0.000608	CcSEcCtD
Zoledronate—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000307	0.000608	CcSEcCtD
Zoledronate—Oedema—Dexamethasone—multiple sclerosis	0.000307	0.000608	CcSEcCtD
Zoledronate—Oedema—Betamethasone—multiple sclerosis	0.000307	0.000608	CcSEcCtD
Zoledronate—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000306	0.000607	CcSEcCtD
Zoledronate—Insomnia—Triamcinolone—multiple sclerosis	0.000306	0.000606	CcSEcCtD
Zoledronate—Insomnia—Methylprednisolone—multiple sclerosis	0.000305	0.000604	CcSEcCtD
Zoledronate—Infection—Betamethasone—multiple sclerosis	0.000305	0.000604	CcSEcCtD
Zoledronate—Infection—Dexamethasone—multiple sclerosis	0.000305	0.000604	CcSEcCtD
Zoledronate—Ill-defined disorder—Prednisone—multiple sclerosis	0.000304	0.000602	CcSEcCtD
Zoledronate—Paraesthesia—Triamcinolone—multiple sclerosis	0.000303	0.000601	CcSEcCtD
Zoledronate—Feeling abnormal—Prednisolone—multiple sclerosis	0.000303	0.0006	CcSEcCtD
Zoledronate—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000303	0.0006	CcSEcCtD
Zoledronate—Anaemia—Prednisone—multiple sclerosis	0.000302	0.000599	CcSEcCtD
Zoledronate—Shock—Betamethasone—multiple sclerosis	0.000302	0.000598	CcSEcCtD
Zoledronate—Shock—Dexamethasone—multiple sclerosis	0.000302	0.000598	CcSEcCtD
Zoledronate—Dyspnoea—Triamcinolone—multiple sclerosis	0.000301	0.000597	CcSEcCtD
Zoledronate—Nervous system disorder—Betamethasone—multiple sclerosis	0.000301	0.000596	CcSEcCtD
Zoledronate—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000301	0.000596	CcSEcCtD
Zoledronate—Agitation—Prednisone—multiple sclerosis	0.000301	0.000596	CcSEcCtD
Zoledronate—Thrombocytopenia—Betamethasone—multiple sclerosis	0.0003	0.000595	CcSEcCtD
Zoledronate—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.0003	0.000595	CcSEcCtD
Zoledronate—Tachycardia—Betamethasone—multiple sclerosis	0.000299	0.000593	CcSEcCtD
Zoledronate—Tachycardia—Dexamethasone—multiple sclerosis	0.000299	0.000593	CcSEcCtD
Zoledronate—Angioedema—Prednisone—multiple sclerosis	0.000299	0.000593	CcSEcCtD
Zoledronate—Dyspepsia—Triamcinolone—multiple sclerosis	0.000297	0.00059	CcSEcCtD
Zoledronate—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000297	0.000588	CcSEcCtD
Zoledronate—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000296	0.000588	CcSEcCtD
Zoledronate—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000296	0.000588	CcSEcCtD
Zoledronate—Malaise—Prednisone—multiple sclerosis	0.000295	0.000585	CcSEcCtD
Zoledronate—Vertigo—Prednisone—multiple sclerosis	0.000294	0.000583	CcSEcCtD
Zoledronate—Eye disorder—Methotrexate—multiple sclerosis	0.000294	0.000582	CcSEcCtD
Zoledronate—Syncope—Prednisone—multiple sclerosis	0.000293	0.000582	CcSEcCtD
Zoledronate—Anorexia—Betamethasone—multiple sclerosis	0.000292	0.000579	CcSEcCtD
Zoledronate—Anorexia—Dexamethasone—multiple sclerosis	0.000292	0.000579	CcSEcCtD
Zoledronate—Urticaria—Prednisolone—multiple sclerosis	0.000292	0.000579	CcSEcCtD
Zoledronate—Cardiac disorder—Methotrexate—multiple sclerosis	0.000291	0.000578	CcSEcCtD
Zoledronate—Fatigue—Triamcinolone—multiple sclerosis	0.000291	0.000577	CcSEcCtD
Zoledronate—Fatigue—Methylprednisolone—multiple sclerosis	0.000291	0.000576	CcSEcCtD
Zoledronate—Pain—Triamcinolone—multiple sclerosis	0.000289	0.000573	CcSEcCtD
Zoledronate—Loss of consciousness—Prednisone—multiple sclerosis	0.000288	0.00057	CcSEcCtD
Zoledronate—Hypotension—Dexamethasone—multiple sclerosis	0.000286	0.000568	CcSEcCtD
Zoledronate—Hypotension—Betamethasone—multiple sclerosis	0.000286	0.000568	CcSEcCtD
Zoledronate—Angiopathy—Methotrexate—multiple sclerosis	0.000285	0.000565	CcSEcCtD
Zoledronate—Vomiting—Mitoxantrone—multiple sclerosis	0.000285	0.000564	CcSEcCtD
Zoledronate—Immune system disorder—Methotrexate—multiple sclerosis	0.000284	0.000562	CcSEcCtD
Zoledronate—Convulsion—Prednisone—multiple sclerosis	0.000283	0.000562	CcSEcCtD
Zoledronate—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000283	0.000561	CcSEcCtD
Zoledronate—Hypertension—Prednisone—multiple sclerosis	0.000282	0.00056	CcSEcCtD
Zoledronate—Rash—Mitoxantrone—multiple sclerosis	0.000282	0.00056	CcSEcCtD
Zoledronate—Dermatitis—Mitoxantrone—multiple sclerosis	0.000282	0.000559	CcSEcCtD
Zoledronate—Chills—Methotrexate—multiple sclerosis	0.000282	0.000559	CcSEcCtD
Zoledronate—Headache—Mitoxantrone—multiple sclerosis	0.000281	0.000556	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000279	0.000554	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000279	0.000554	CcSEcCtD
Zoledronate—Arthralgia—Prednisone—multiple sclerosis	0.000279	0.000552	CcSEcCtD
Zoledronate—Myalgia—Prednisone—multiple sclerosis	0.000279	0.000552	CcSEcCtD
Zoledronate—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000278	0.000552	CcSEcCtD
Zoledronate—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000278	0.000551	CcSEcCtD
Zoledronate—Anxiety—Prednisone—multiple sclerosis	0.000278	0.00055	CcSEcCtD
Zoledronate—Alopecia—Methotrexate—multiple sclerosis	0.000278	0.00055	CcSEcCtD
Zoledronate—Insomnia—Dexamethasone—multiple sclerosis	0.000277	0.00055	CcSEcCtD
Zoledronate—Insomnia—Betamethasone—multiple sclerosis	0.000277	0.00055	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000277	0.000548	CcSEcCtD
Zoledronate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000276	0.000546	CcSEcCtD
Zoledronate—Paraesthesia—Dexamethasone—multiple sclerosis	0.000275	0.000546	CcSEcCtD
Zoledronate—Paraesthesia—Betamethasone—multiple sclerosis	0.000275	0.000546	CcSEcCtD
Zoledronate—Discomfort—Prednisone—multiple sclerosis	0.000275	0.000545	CcSEcCtD
Zoledronate—Mental disorder—Methotrexate—multiple sclerosis	0.000275	0.000545	CcSEcCtD
Zoledronate—Erythema—Methotrexate—multiple sclerosis	0.000273	0.000542	CcSEcCtD
Zoledronate—Malnutrition—Methotrexate—multiple sclerosis	0.000273	0.000542	CcSEcCtD
Zoledronate—Hypersensitivity—Prednisolone—multiple sclerosis	0.000271	0.000537	CcSEcCtD
Zoledronate—Dyspepsia—Betamethasone—multiple sclerosis	0.00027	0.000535	CcSEcCtD
Zoledronate—Dyspepsia—Dexamethasone—multiple sclerosis	0.00027	0.000535	CcSEcCtD
Zoledronate—Urticaria—Triamcinolone—multiple sclerosis	0.000268	0.000532	CcSEcCtD
Zoledronate—Urticaria—Methylprednisolone—multiple sclerosis	0.000268	0.000531	CcSEcCtD
Zoledronate—Dysgeusia—Methotrexate—multiple sclerosis	0.000268	0.000531	CcSEcCtD
Zoledronate—Body temperature increased—Triamcinolone—multiple sclerosis	0.000267	0.000529	CcSEcCtD
Zoledronate—Anaphylactic shock—Prednisone—multiple sclerosis	0.000267	0.000529	CcSEcCtD
Zoledronate—Oedema—Prednisone—multiple sclerosis	0.000267	0.000529	CcSEcCtD
Zoledronate—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000267	0.000528	CcSEcCtD
Zoledronate—Decreased appetite—Betamethasone—multiple sclerosis	0.000267	0.000528	CcSEcCtD
Zoledronate—Decreased appetite—Dexamethasone—multiple sclerosis	0.000267	0.000528	CcSEcCtD
Zoledronate—Nausea—Mitoxantrone—multiple sclerosis	0.000266	0.000527	CcSEcCtD
Zoledronate—Infection—Prednisone—multiple sclerosis	0.000265	0.000526	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000265	0.000525	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000265	0.000525	CcSEcCtD
Zoledronate—Back pain—Methotrexate—multiple sclerosis	0.000264	0.000524	CcSEcCtD
Zoledronate—Fatigue—Betamethasone—multiple sclerosis	0.000264	0.000524	CcSEcCtD
Zoledronate—Fatigue—Dexamethasone—multiple sclerosis	0.000264	0.000524	CcSEcCtD
Zoledronate—Shock—Prednisone—multiple sclerosis	0.000263	0.000521	CcSEcCtD
Zoledronate—Pain—Dexamethasone—multiple sclerosis	0.000262	0.00052	CcSEcCtD
Zoledronate—Pain—Betamethasone—multiple sclerosis	0.000262	0.00052	CcSEcCtD
Zoledronate—Nervous system disorder—Prednisone—multiple sclerosis	0.000262	0.000519	CcSEcCtD
Zoledronate—Tachycardia—Prednisone—multiple sclerosis	0.000261	0.000517	CcSEcCtD
Zoledronate—Skin disorder—Prednisone—multiple sclerosis	0.000259	0.000514	CcSEcCtD
Zoledronate—Hyperhidrosis—Prednisone—multiple sclerosis	0.000258	0.000512	CcSEcCtD
Zoledronate—Vision blurred—Methotrexate—multiple sclerosis	0.000258	0.000511	CcSEcCtD
Zoledronate—Anorexia—Prednisone—multiple sclerosis	0.000255	0.000504	CcSEcCtD
Zoledronate—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000254	0.000503	CcSEcCtD
Zoledronate—Anaemia—Methotrexate—multiple sclerosis	0.000253	0.000501	CcSEcCtD
Zoledronate—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000253	0.000501	CcSEcCtD
Zoledronate—Feeling abnormal—Betamethasone—multiple sclerosis	0.000253	0.000501	CcSEcCtD
Zoledronate—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000251	0.000497	CcSEcCtD
Zoledronate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000251	0.000497	CcSEcCtD
Zoledronate—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000249	0.000493	CcSEcCtD
Zoledronate—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000248	0.000492	CcSEcCtD
Zoledronate—Malaise—Methotrexate—multiple sclerosis	0.000247	0.000489	CcSEcCtD
Zoledronate—Vertigo—Methotrexate—multiple sclerosis	0.000246	0.000487	CcSEcCtD
Zoledronate—Leukopenia—Methotrexate—multiple sclerosis	0.000245	0.000485	CcSEcCtD
Zoledronate—Urticaria—Dexamethasone—multiple sclerosis	0.000244	0.000483	CcSEcCtD
Zoledronate—Urticaria—Betamethasone—multiple sclerosis	0.000244	0.000483	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000243	0.000482	CcSEcCtD
Zoledronate—Dizziness—Prednisolone—multiple sclerosis	0.000243	0.000482	CcSEcCtD
Zoledronate—Asthenia—Triamcinolone—multiple sclerosis	0.000242	0.000481	CcSEcCtD
Zoledronate—Abdominal pain—Betamethasone—multiple sclerosis	0.000242	0.00048	CcSEcCtD
Zoledronate—Abdominal pain—Dexamethasone—multiple sclerosis	0.000242	0.00048	CcSEcCtD
Zoledronate—Body temperature increased—Dexamethasone—multiple sclerosis	0.000242	0.00048	CcSEcCtD
Zoledronate—Body temperature increased—Betamethasone—multiple sclerosis	0.000242	0.00048	CcSEcCtD
Zoledronate—Asthenia—Methylprednisolone—multiple sclerosis	0.000242	0.000479	CcSEcCtD
Zoledronate—Insomnia—Prednisone—multiple sclerosis	0.000241	0.000479	CcSEcCtD
Zoledronate—Paraesthesia—Prednisone—multiple sclerosis	0.00024	0.000475	CcSEcCtD
Zoledronate—Pruritus—Triamcinolone—multiple sclerosis	0.000239	0.000474	CcSEcCtD
Zoledronate—Cough—Methotrexate—multiple sclerosis	0.000239	0.000473	CcSEcCtD
Zoledronate—Pruritus—Methylprednisolone—multiple sclerosis	0.000239	0.000473	CcSEcCtD
Zoledronate—Convulsion—Methotrexate—multiple sclerosis	0.000237	0.00047	CcSEcCtD
Zoledronate—Dyspepsia—Prednisone—multiple sclerosis	0.000235	0.000466	CcSEcCtD
Zoledronate—Chest pain—Methotrexate—multiple sclerosis	0.000233	0.000461	CcSEcCtD
Zoledronate—Myalgia—Methotrexate—multiple sclerosis	0.000233	0.000461	CcSEcCtD
Zoledronate—Arthralgia—Methotrexate—multiple sclerosis	0.000233	0.000461	CcSEcCtD
Zoledronate—Decreased appetite—Prednisone—multiple sclerosis	0.000232	0.00046	CcSEcCtD
Zoledronate—Rash—Prednisolone—multiple sclerosis	0.000232	0.000459	CcSEcCtD
Zoledronate—Dermatitis—Prednisolone—multiple sclerosis	0.000231	0.000459	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000231	0.000458	CcSEcCtD
Zoledronate—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000231	0.000457	CcSEcCtD
Zoledronate—Fatigue—Prednisone—multiple sclerosis	0.00023	0.000456	CcSEcCtD
Zoledronate—Headache—Prednisolone—multiple sclerosis	0.00023	0.000456	CcSEcCtD
Zoledronate—Discomfort—Methotrexate—multiple sclerosis	0.00023	0.000456	CcSEcCtD
Zoledronate—Constipation—Prednisone—multiple sclerosis	0.000228	0.000453	CcSEcCtD
Zoledronate—Confusional state—Methotrexate—multiple sclerosis	0.000225	0.000446	CcSEcCtD
Zoledronate—Dizziness—Triamcinolone—multiple sclerosis	0.000223	0.000443	CcSEcCtD
Zoledronate—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000223	0.000442	CcSEcCtD
Zoledronate—Dizziness—Methylprednisolone—multiple sclerosis	0.000223	0.000442	CcSEcCtD
Zoledronate—Infection—Methotrexate—multiple sclerosis	0.000222	0.000439	CcSEcCtD
Zoledronate—Feeling abnormal—Prednisone—multiple sclerosis	0.00022	0.000436	CcSEcCtD
Zoledronate—Asthenia—Dexamethasone—multiple sclerosis	0.00022	0.000436	CcSEcCtD
Zoledronate—Asthenia—Betamethasone—multiple sclerosis	0.00022	0.000436	CcSEcCtD
Zoledronate—Nervous system disorder—Methotrexate—multiple sclerosis	0.000219	0.000434	CcSEcCtD
Zoledronate—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000218	0.000433	CcSEcCtD
Zoledronate—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000218	0.000433	CcSEcCtD
Zoledronate—Nausea—Prednisolone—multiple sclerosis	0.000218	0.000433	CcSEcCtD
Zoledronate—Pruritus—Dexamethasone—multiple sclerosis	0.000217	0.00043	CcSEcCtD
Zoledronate—Pruritus—Betamethasone—multiple sclerosis	0.000217	0.00043	CcSEcCtD
Zoledronate—Skin disorder—Methotrexate—multiple sclerosis	0.000217	0.00043	CcSEcCtD
Zoledronate—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000216	0.000428	CcSEcCtD
Zoledronate—Vomiting—Triamcinolone—multiple sclerosis	0.000215	0.000426	CcSEcCtD
Zoledronate—Vomiting—Methylprednisolone—multiple sclerosis	0.000214	0.000425	CcSEcCtD
Zoledronate—Rash—Triamcinolone—multiple sclerosis	0.000213	0.000422	CcSEcCtD
Zoledronate—Dermatitis—Triamcinolone—multiple sclerosis	0.000213	0.000422	CcSEcCtD
Zoledronate—Anorexia—Methotrexate—multiple sclerosis	0.000213	0.000422	CcSEcCtD
Zoledronate—Rash—Methylprednisolone—multiple sclerosis	0.000213	0.000421	CcSEcCtD
Zoledronate—Dermatitis—Methylprednisolone—multiple sclerosis	0.000212	0.000421	CcSEcCtD
Zoledronate—Urticaria—Prednisone—multiple sclerosis	0.000212	0.00042	CcSEcCtD
Zoledronate—Headache—Triamcinolone—multiple sclerosis	0.000212	0.00042	CcSEcCtD
Zoledronate—Headache—Methylprednisolone—multiple sclerosis	0.000211	0.000419	CcSEcCtD
Zoledronate—Abdominal pain—Prednisone—multiple sclerosis	0.000211	0.000418	CcSEcCtD
Zoledronate—Body temperature increased—Prednisone—multiple sclerosis	0.000211	0.000418	CcSEcCtD
Zoledronate—Diarrhoea—Betamethasone—multiple sclerosis	0.00021	0.000416	CcSEcCtD
Zoledronate—Diarrhoea—Dexamethasone—multiple sclerosis	0.00021	0.000416	CcSEcCtD
Zoledronate—Hypotension—Methotrexate—multiple sclerosis	0.000209	0.000413	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000203	0.000403	CcSEcCtD
Zoledronate—Dizziness—Dexamethasone—multiple sclerosis	0.000203	0.000402	CcSEcCtD
Zoledronate—Dizziness—Betamethasone—multiple sclerosis	0.000203	0.000402	CcSEcCtD
Zoledronate—Insomnia—Methotrexate—multiple sclerosis	0.000202	0.0004	CcSEcCtD
Zoledronate—Nausea—Triamcinolone—multiple sclerosis	0.000201	0.000398	CcSEcCtD
Zoledronate—Paraesthesia—Methotrexate—multiple sclerosis	0.0002	0.000397	CcSEcCtD
Zoledronate—Nausea—Methylprednisolone—multiple sclerosis	0.0002	0.000397	CcSEcCtD
Zoledronate—Dyspnoea—Methotrexate—multiple sclerosis	0.000199	0.000394	CcSEcCtD
Zoledronate—Somnolence—Methotrexate—multiple sclerosis	0.000198	0.000393	CcSEcCtD
Zoledronate—Hypersensitivity—Prednisone—multiple sclerosis	0.000197	0.00039	CcSEcCtD
Zoledronate—Dyspepsia—Methotrexate—multiple sclerosis	0.000196	0.000389	CcSEcCtD
Zoledronate—Vomiting—Dexamethasone—multiple sclerosis	0.000195	0.000386	CcSEcCtD
Zoledronate—Vomiting—Betamethasone—multiple sclerosis	0.000195	0.000386	CcSEcCtD
Zoledronate—Decreased appetite—Methotrexate—multiple sclerosis	0.000194	0.000384	CcSEcCtD
Zoledronate—Rash—Betamethasone—multiple sclerosis	0.000193	0.000383	CcSEcCtD
Zoledronate—Rash—Dexamethasone—multiple sclerosis	0.000193	0.000383	CcSEcCtD
Zoledronate—Dermatitis—Betamethasone—multiple sclerosis	0.000193	0.000383	CcSEcCtD
Zoledronate—Dermatitis—Dexamethasone—multiple sclerosis	0.000193	0.000383	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000193	0.000382	CcSEcCtD
Zoledronate—Fatigue—Methotrexate—multiple sclerosis	0.000192	0.000381	CcSEcCtD
Zoledronate—Headache—Dexamethasone—multiple sclerosis	0.000192	0.000381	CcSEcCtD
Zoledronate—Headache—Betamethasone—multiple sclerosis	0.000192	0.000381	CcSEcCtD
Zoledronate—Asthenia—Prednisone—multiple sclerosis	0.000192	0.00038	CcSEcCtD
Zoledronate—Pain—Methotrexate—multiple sclerosis	0.000191	0.000378	CcSEcCtD
Zoledronate—Pruritus—Prednisone—multiple sclerosis	0.000189	0.000374	CcSEcCtD
Zoledronate—Feeling abnormal—Methotrexate—multiple sclerosis	0.000184	0.000364	CcSEcCtD
Zoledronate—Diarrhoea—Prednisone—multiple sclerosis	0.000183	0.000362	CcSEcCtD
Zoledronate—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000182	0.000362	CcSEcCtD
Zoledronate—Nausea—Dexamethasone—multiple sclerosis	0.000182	0.000361	CcSEcCtD
Zoledronate—Nausea—Betamethasone—multiple sclerosis	0.000182	0.000361	CcSEcCtD
Zoledronate—Urticaria—Methotrexate—multiple sclerosis	0.000177	0.000351	CcSEcCtD
Zoledronate—Dizziness—Prednisone—multiple sclerosis	0.000177	0.00035	CcSEcCtD
Zoledronate—Abdominal pain—Methotrexate—multiple sclerosis	0.000176	0.00035	CcSEcCtD
Zoledronate—Body temperature increased—Methotrexate—multiple sclerosis	0.000176	0.00035	CcSEcCtD
Zoledronate—Vomiting—Prednisone—multiple sclerosis	0.00017	0.000337	CcSEcCtD
Zoledronate—Rash—Prednisone—multiple sclerosis	0.000168	0.000334	CcSEcCtD
Zoledronate—Dermatitis—Prednisone—multiple sclerosis	0.000168	0.000333	CcSEcCtD
Zoledronate—Headache—Prednisone—multiple sclerosis	0.000167	0.000332	CcSEcCtD
Zoledronate—Hypersensitivity—Methotrexate—multiple sclerosis	0.000164	0.000326	CcSEcCtD
Zoledronate—Asthenia—Methotrexate—multiple sclerosis	0.00016	0.000317	CcSEcCtD
Zoledronate—Nausea—Prednisone—multiple sclerosis	0.000159	0.000314	CcSEcCtD
Zoledronate—Pruritus—Methotrexate—multiple sclerosis	0.000158	0.000313	CcSEcCtD
Zoledronate—Diarrhoea—Methotrexate—multiple sclerosis	0.000153	0.000303	CcSEcCtD
Zoledronate—Dizziness—Methotrexate—multiple sclerosis	0.000148	0.000292	CcSEcCtD
Zoledronate—Vomiting—Methotrexate—multiple sclerosis	0.000142	0.000281	CcSEcCtD
Zoledronate—Rash—Methotrexate—multiple sclerosis	0.000141	0.000279	CcSEcCtD
Zoledronate—Dermatitis—Methotrexate—multiple sclerosis	0.000141	0.000279	CcSEcCtD
Zoledronate—Headache—Methotrexate—multiple sclerosis	0.00014	0.000277	CcSEcCtD
Zoledronate—Nausea—Methotrexate—multiple sclerosis	0.000133	0.000263	CcSEcCtD
